Literature DB >> 26733478

Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.

Imke Schamarek1, Christian Herder2, Bettina Nowotny1, Maren Carstensen-Kirberg1, Klaus Straßburger1, Peter Nowotny1, Alexander Strom1, Sonja Püttgen1, Karsten Müssig3, Julia Szendroedi3, Michael Roden3, Dan Ziegler3.   

Abstract

OBJECTIVE: Subclinical inflammation has been implicated in the development of diabetic sensorimotor polyneuropathy (DSPN), but studies using electrophysiological assessment as outcomes are scarce. Therefore, we aimed to investigate associations of biomarkers reflecting different aspects of subclinical inflammation with motor and sensory nerve conduction velocity (NCV) in individuals with diabetes. DESIGN AND METHODS: Motor and sensory NCV was assessed in individuals with recently diagnosed type 2 (n=352) or type 1 diabetes (n=161) from the baseline cohort of the observational German Diabetes Study. NCV sum scores were calculated for median, ulnar and peroneal motor as well as median, ulnar and sural sensory nerves. Associations between inflammation-related biomarkers, DSPN and NCV sum scores were estimated using multiple regression models.
RESULTS: In type 2 diabetes, high serum interleukin (IL)-6 was associated with the presence of DSPN and reduced motor NCV. Moreover, higher levels of high-molecular weight (HMW) adiponectin, total adiponectin and their ratio were associated with prevalent DSPN and both diminished motor and sensory NCV, whereas no consistent associations were observed for C-reactive protein, IL18, soluble intercellular adhesion molecule-1 and E-selectin. In type 1 diabetes, only HMW and total adiponectin showed positive associations with motor NCV.
CONCLUSIONS: Our results point to a link between IL6 and both DSPN and slowed motor NCV in recently diagnosed type 2 diabetes. The reverse associations between adiponectin and NCV in type 1 and type 2 diabetes are intriguing, and further studies should explore whether they may reflect differences in the pathogenesis of DSPN in both diabetes types.
© 2016 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26733478     DOI: 10.1530/EJE-15-1010

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

Review 1.  Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes.

Authors:  Christian Herder; Norbert Hermanns
Journal:  Semin Immunopathol       Date:  2019-02-18       Impact factor: 9.623

Review 2.  Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.

Authors:  Gordon Sloan; Dinesh Selvarajah; Solomon Tesfaye
Journal:  Nat Rev Endocrinol       Date:  2021-05-28       Impact factor: 43.330

Review 3.  Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?

Authors:  Mark Yorek
Journal:  Curr Diabetes Rev       Date:  2022

4.  Cohort profile: the German Diabetes Study (GDS).

Authors:  Julia Szendroedi; Aaruni Saxena; Katharina S Weber; Klaus Strassburger; Christian Herder; Volker Burkart; Bettina Nowotny; Andrea Icks; Oliver Kuss; Dan Ziegler; Hadi Al-Hasani; Karsten Müssig; Michael Roden
Journal:  Cardiovasc Diabetol       Date:  2016-04-07       Impact factor: 9.951

Review 5.  Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.

Authors:  Luis Miguel Román-Pintos; Geannyne Villegas-Rivera; Adolfo Daniel Rodríguez-Carrizalez; Alejandra Guillermina Miranda-Díaz; Ernesto Germán Cardona-Muñoz
Journal:  J Diabetes Res       Date:  2016-12-12       Impact factor: 4.011

6.  Lower serum extracellular superoxide dismutase levels are associated with polyneuropathy in recent-onset diabetes.

Authors:  Alexander Strom; Kirti Kaul; Jutta Brüggemann; Iris Ziegler; Ilka Rokitta; Sonja Püttgen; Julia Szendroedi; Karsten Müssig; Michael Roden; Dan Ziegler
Journal:  Exp Mol Med       Date:  2017-11-17       Impact factor: 8.718

7.  Effect of diabetes type on long-term outcome of epidermal axon regeneration.

Authors:  Mohammad Khoshnoodi; Shaun Truelove; Michael Polydefkis
Journal:  Ann Clin Transl Neurol       Date:  2019-09-27       Impact factor: 4.511

8.  Associations of cells from both innate and adaptive immunity with lower nerve conduction velocity: the Maastricht Study.

Authors:  Haifa Maalmi; Kristiaan Wouters; Christian Herder; Nicolaas C Schaper; Hans H C M Savelberg; Jeroen H P M van der Velde; Jos P H Reulen; Werner Mess; Casper G Schalkwijk; Coen D A Stehouwer; Michael Roden; Dan Ziegler
Journal:  BMJ Open Diabetes Res Care       Date:  2021-01

Review 9.  Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes: A Systematic Review.

Authors:  Mar Sempere-Bigorra; Iván Julián-Rochina; Omar Cauli
Journal:  J Pers Med       Date:  2021-03-22

10.  Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.

Authors:  Elhadi H Aburawi; Juma AlKaabi; Taoufik Zoubeidi; Abdullah Shehab; Nader Lessan; Awad Al Essa; Javed Yasin; Hussain Saadi; Abdul-Kader Souid
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.